Shares of Arena Pharmaceuticals slid 3.66% to $74.32 at 16:39 EST on Monday, following last session’s downward trend. NASDAQ Composite is sliding 1.25% to $13,036.43, after two successive sessions in a row of gains. This seems, so far, an all-around rough trend trading session today.

Arena Pharmaceuticals’s last close was $77.14, 21.35% below its 52-week high of $90.19.

Arena Pharmaceuticals’s Sales

Arena Pharmaceuticals’s sales growth is a negative 81.3% for the current quarter and 155.7% for the next. The company’s growth estimates for the ongoing quarter is a negative 4.5% and positive 4.5% for the next.

Arena Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth declined by 98.5%, now sitting on 3.28M for the twelve trailing months.


Arena Pharmaceuticals’s last day, last week, and last month’s average volatility was a negative 0.58%, a positive 0.08%, and a positive 0.52%, respectively.

Arena Pharmaceuticals’s last day, last week, and last month’s high and low average amplitude percentage was 3.33%, 3.32%, and 3.32%, respectively.

Arena Pharmaceuticals’s Stock Yearly Top and Bottom Value

Arena Pharmaceuticals’s stock is valued at $74.32 at 16:39 EST, way below its 52-week high of $90.19 and way higher than its 52-week low of $32.95.

Arena Pharmaceuticals’s Moving Average

Arena Pharmaceuticals’s value is above its 50-day moving average of $71.53 and higher than its 200-day moving average of $70.82.


Please enter your comment!
Please enter your name here